Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

[Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients].

Shioiri M, Hasegawa M, Tanaka H, Toura I, Kudo S, Sato K, Inoue K, Nakanishi T, Nishiyama S, Takebe S, Ogino Y, Ohsaki S, Nagashima Y.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2198-200. Japanese.

PMID:
23268022
2.

Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.

Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, Taniguchi M.

J Immunol. 1999 Sep 1;163(5):2387-91.

3.

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, Kondo E, Harada M, Koseki H, Nakayama T, Tanaka Y, Taniguchi M.

Proc Natl Acad Sci U S A. 1998 May 12;95(10):5690-3.

4.

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M.

Science. 1997 Nov 28;278(5343):1626-9.

5.

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M.

Science. 1997 Nov 28;278(5343):1623-6.

Supplemental Content

Support Center